🇺🇸 FDA
Patent

US 8044189

Bacillus anthracis protective antigen nucleic acid sequences

granted A61KA61K2039/505A61K2039/53

Quick answer

US patent 8044189 (Bacillus anthracis protective antigen nucleic acid sequences) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/505, A61K2039/53, A61K39/00, A61P